Polycystic kidney disease: novel insights into polycystin function

Trends Mol Med. 2023 Apr;29(4):268-281. doi: 10.1016/j.molmed.2023.01.005. Epub 2023 Feb 15.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening monogenic disease caused by mutations in PKD1 and PKD2 that encode polycystin 1 (PC1) and polycystin 2 (PC2). PC1/2 localize to cilia of renal epithelial cells, and their function is believed to embody an inhibitory activity that suppresses the cilia-dependent cyst activation (CDCA) signal. Consequently, PC deficiency results in activation of CDCA and stimulates cyst growth. Recently, re-expression of PCs in established cysts has been shown to reverse PKD. Thus, the mode of action of PCs resembles a 'counterbalance in cruise control' to maintain lumen diameter within a designated range. Herein we review recent studies that point to novel arenas for future PC research with therapeutic potential for ADPKD.

Keywords: ADPKD; CDCA; cation channel; cilia; lumen diameter control; polycystin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cysts* / complications
  • Humans
  • Kidney / metabolism
  • Polycystic Kidney Diseases* / complications
  • Polycystic Kidney Diseases* / genetics
  • Polycystic Kidney, Autosomal Dominant* / genetics
  • Signal Transduction
  • TRPP Cation Channels / genetics
  • TRPP Cation Channels / metabolism

Substances

  • TRPP Cation Channels